ABSTRACT In the investigation of suspected lung cancer bleomycin labelled with cobalt-57 and gallium-67 labelled with citrate are currently used to detect the primary tumour and to establish the presence of metastases in the lung hilum and mediastinum. A comparative study of these radiopharmaceuticals was performed in 63 patients with proved lung cancer. 57Co-bleomycin showed the primary tumour in 58 patients (92%) and 67Ga-citrate in 34 (54%) (p < 0 01). The average tumour-to-lung ratio was 3 4 with 57Co-bleomycin and 1 5 with 67Ga-citrate. 
should be carried out; but when no metastases are apparent it is reasonable to proceed directly to thoracotomy without mediastinoscopy.
In patients with a peripheral lesion on the chest radiograph a diagnosis is often difficult to establish. Cytological examination.of the sputum is not always conclusive. ' Furthermore, it is frequently not possible to obtain a biopsy specimen to provide a histological diagnosis.2 When the diagnosis of bronchial carcinoma is established, staging is of the utmost importance. Patients with cancers other than small-cell are traditionally considered suitable for surgical removal of the affected lobe or lung only in the absence of hilar and mediastinal metastases,3 although lately a more aggressive approach has sometimes been advocated.45 The mediastinum can be evaluated by mediastinoscopy; but because of the morbidity it causes this is not considered a minor surgical procedure, and only part of the mediastinum can be explored this way. A non-invasive method that reduces the need for mediastinoscopy would be highly desirable.6 Scintigraphy using gallium-67-citrate and bleomycin labelled with cobalt-57 has been reported to be useful in establishing the malignant nature of a lesion seen on the chest radiograph.78 Furthermore, both radiopharmaceuticals are in use for the detection of lymph-node metastases in the hilum and mediastinum.9 '°I t has been suggested that "Co-bleomycin is more suitable than 67Ga-citrate for the detection of primary lung cancer,"- '' but no comparative study of the detection of metastases in the hilum or mediastinum has been published to our knowledge. In this paper we present evidence that "Co-bleomycin is superior to 67Ga-citrate for both purposes.
Methods
The criteria for selection of patients included (a) the need to investigate a peripheral lesion of unknown origin seen on the chest radiograph and (b) the need to detect possible metastases in the hilum and mediastinum. Most patients were referred because of a small symptomless lesion on a chest radiograph from a mass screening programme.
Scintigraphy was performed in 93 patients.
Informed consent was obtained. Of these patients, 23 were excluded because of lack of histological confirmation. Of the remaining 70 patients, 63 were 57Co-bleomycin and 67Ga-citrate in detecting and staging lung cancer men and seven were women. Scintigraphy was performed with a large-field gamma camera. During the 57Co-scintigraphy a lowenergy, parallel-hole collimator was used. A preset count of 50 k and a preset time of 10 minutes were used. During the 6"Ga-scintigraphy a medium-energy parallel-hole collimator was used. The 296-keV and 184-keV photopeaks were used. A preset count of 400 k and a preset time of 10 minutes were selected. Anterior and posterior views of the thorax were obtained and other views if necessary.
All scintigrams were reviewed as unprocessed analogue pictures by several of the authors without knowledge of the pathological diagnosis and a consensus interpretation was made. The results of the scans were expressed as positive, equivocal, or negative. Scintigrams were also accumulated in a computer system in 64 x 64 frame mode. Tumour-tolung uptake ratios were calculated from the digital pictures with the following technique. A rectangular region of interest was chosen around the tumour. A lower display level was set to visualise the tumour only and the mean count per channel in the visible part of the region was calculated. This was divided by the mean count per channel of a similar 
The size of the lesions, measurable on the chest radiographs in 57 patients, influenced the scintigraphy results. The mean diameter of the lesions measured was 3-7 cm (range 1(0-83 cm). The diameters of the tumours in the patients with false negative 57Co-bleomycin scintigrams were 3 7, 1-7, Tumours smaller than 3 cm were seldom visualised with 6"Ga-citrate. An tThis patient also had squamous-cell carcinoma.
Discussion
Clinical staging of lung cancer is important for several reasons'5--firstly, to aid the selection of the most effective treatment; secondly, to assist in determining prognosis; and, thirdly, to allow comparison of endresults reported from different sources. 67Ga-citrate is widely used for this purpose; 57Co-bleomycin is used on a smaller scale. After the first paper on the use of 67Ga-citrate as a tumourseeking agent 16 initially encouraging results in detecting lung cancer were reported. In 1217 patients, collected from different publications, a sensitivity of 91% was found. '7 Later it became evident that a negative scan could not be relied on in the case of lesions less than 3 cm in diameter. ' The detection of mediastinal metastases proved disappointing, possibly because of the high uptake normally seen in this region. 18 Recently it was stated that the detection of hilar and mediastinal tumour extension with 6'Ga-citrate is still highly controversial.6 A considerable number of falsepositive'9 and false-negative scintigrams has been reported.20 Possibly a higher dose, up to 10 mCi (370 MBq),2' more refined equipment such as a tomographic system,22 injection of iron, or injection of desferoxamine mesylate after 67Ga-citrate injection25 would improve the sensitivity. Another disadvantage of 67Ga-citrate is its rather poor specificity-it is concentrated in benign lesions such as inflammation26 and sarcoidosis lesions. '2 found a sensitivity of 91% with 57Co-bleomycin and 76% with 6"Ga-citrate in patients with lung cancer. The latter figure is better than our results. In the present study tumour-to-lung ratios for 57Co-bleomycin were clearly better: 3 4 compared with 1-5 for 67Ga-citrate. Bertrand et al compared tumour-to-lung ratios in 21 patients with lung cancer and found a ratio of 5-2 for 57Co-bleomycin and of 2-1 for 67Ga-citrate. ' 3 Detection of hilar and mediastinal metastases proved more reliable with 57Co-bleomycin in our study. In none of the few comparative studies that we know of were the hilum and mediastinum evaluated, yet these areas are of great clinical importance.
The size of the lesion plays an important part in its detection with radiopharmaceuticals. Patients with a large primary tumour, in whom a diagnosis could easily be established by other means, were excluded from this study. Patients with obvious clinical or radiological signs of hilar or mediastinal metastases were also excluded. They were subjected to mediastinoscopy without prior scintigraphy. In most of our patients the lesion was discovered on mass screening radiographs, when symptoms had not yet developed. As a result most of the patients studied had a small tumour. This may explain our unfavourable results with 67Ga-scintigraphy. The importance of the tumour size for the scintigraphy results is shown in fig 1. The major drawback of 5"Co, its long half life, poses no threat to the patient since 57Co-bleomycin is quickly excreted by the kidneys; but the urine should be collected for at least 24 hours and stored to prevent environmental contamination. Using "Co as label for bleomycin solves this problem. Our first results with "Co-bleomycin in the detection of lung cancer, with a positron camera, are promising. 29 We do not advocate that 57Co-bleomycin should replace biopsy and histological diagnosis of the primary tumour; but in peripheral lesions, in which a pathological diagnosis is difficult to obtain, a positive scintigram is an indication of a malignancy. When hilar or mediastinal metastases are suggested by scintigraphy, mediastinoscopy is carried out. If mediastinoscopy provides histological evidence of metastases thoracotomy is not indicated. When no hilar or mediastinal metastases are shown on the scintigram (and in the absence of distant metastases) we consider that mediastinoscopy is not needed. We then proceed directly to thoracotomy. This study was supported by a grant from the Dutch Cancer Foundation, Koningin Wilhelmina Fonds. The secretarial assistance of Miss E Sijtsema is gratefully acknowledged.
